Covid-19 News

  • Ivermectin outpatient study

    External Content
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • Do you really think the doctors would go before the public and say he got antibody treatment, but they were lying? You don't think someone would find out?

    You have strange imagination. You believe any damn conspiracy theory, no matter how absurd or impossible, if it lets you disbelieve the prosaic truth. Why are you so anxious to avoid believing uncontroversial things? Why does it even matter whether Trump got one treatment rather than another? Assuming you believe in the magical cock-and-bull treatments you advocate, surely that means other treatments also work? If the kind of garbage you promote actually works, then just about anything should work. Eye of newt and toe of frog. A glass of orange juice and a magic spell. It is amazing anyone every gets sick, if that's all it takes is to cure anything.

    Mirror, meet Jed,

    Jed, mirror

  • Nutritional status of patients with COVID-19…cle/pii/S1201971220306470


    Nutrients play a vital role in the defense against infectious diseases and the regulation of inflammation; however, little is known with regards to COVID-19.

    We measured concentrations of vitamins B1, B6, B12, folate, vitamin D (25-hydroxyvitamin D), selenium, and zinc in 50 patients with COVID-19. Vitamin D deficiency was shown in 76% of patients and selenium deficiency in 42%. There was a significant difference compared to a control group of 150 people (vitamin D deficiency 43.3%).

    Among 12 patients with respiratory distress, 11 (91.7%) had one or more nutrient deficiency.

  • Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers

    In Current study authors found that vitamin D deficiency (as suggested by serum 25 (OH)D concentration < 20 ng/mL) is far more prevalent in patients with severe COVID–19 disease requiring ICU admission and thereby increased chances of mortality. For non-skeletal purpose many researchers had suggested cutoff level of serum 25 (OH)D to < 30 ng/ml for defining vitamin D deficiency15, on adopting this criterion the prevalence was almost 100% in critically ill patients (62 out of 63). On the same side the patients with vitamin D deficiency exhibit higher levels of chemical markers of inflammation. The current study is the first and the most comprehensive study in which both severe and asymptomatic COVID patients were included and vitamin D level along with inflammatory markers were estimated the so as to correlate the association. In current study authors preferred of using period-based inclusion of subject over specifying the sample size because of the reason that COVID-19 is an emerging pandemic with variable level of seropositivity in the society and none of the sample size formula fits well with satisfactory reduction in the chances of error. Authors adopted 6-week criterion for inclusion of eligible subjects which is around 10.71% of year (56 weeks). Beside this all the subjects were followed till the closure that is successful discharge or mortality.

  • New Research May Explain Severe Virus Attacks on the Lungs, Contribute to Future Treatments for COVID-19…-treatments-for-covid-19/

    In some cases, immune cells in the lungs can contribute to worsening a virus attack. In a new study, researchers at Karolinska Institutet in Sweden describe how different kinds of immune cells, called macrophages, develop in the lungs and which of them may be behind severe lung diseases. The study, which was published in Immunity, may contribute to future treatments for COVID-19, among other diseases.

  • Thailand Clears Use of Herbal Medicine for Covid-19 Treatment…ne-for-covid-19-treatment

    Andrographis Paniculata, commonly known as green chiretta, will serve as an alternative treatment to reduce the severity of the outbreak and cut treatment costs, the ministry said in a statement Wednesday. The treatment will be available in five state-owned hospital initially, it said.

    The herbal treatment will be on a voluntary basis for those in the 18-60 age group with minor symptoms and should be within 72 hours of confirming infections

    The extract from the plant, known as Fah Talai Jone in Thai, can curb virus and reduce severity of inflammation, ministry says citing studies

    Human trials showed patient conditions improved within three days of the treatment without side effects if the medicine is administered within 72 hours of testing positive

  • Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide

    Andrographis paniculata (Burm. F) Nees, generally known as “king of bitters,” is an herbaceous plant in the family Acanthaceae. In China, India, Thailand, and Malaysia, this plant has been widely used for treating sore throat, flu, and upper respiratory tract infections. Andrographolide, a major bioactive chemical constituent of the plant, has shown anticancer potential in various investigations. Andrographolide and its derivatives have anti-inflammatory effects in experimental models asthma, stroke, and arthritis. In recent years, pharmaceutical chemists have synthesized numerous andrographolide derivatives, which exhibit essential pharmacological activities such as those that are anti-inflammatory, antibacterial, antitumor, antidiabetic, anti-HIV, antifeedant, and antiviral. However, what is noteworthy about this paper is summarizing the effects of andrographolide against cardiovascular disease, platelet activation, infertility, and NF-κB activation. Therefore, this paper is intended to provide evidence reported in relevant literature on qualitative research to assist scientists in isolating and characterizing bioactive compounds.

  • Yes that section requires contraception for 28 days after the final dose -- to exclude pregnant women from the study. (Generic precaution.)

    ".. births [recte birth] defects due to genetic manipulation" is bogus.

    The word 'pregnancy' occurs about 47 times, genetics 7 -- just in general.
    If a live birth occurs, it must be evaluated. A live birth with problems is a "SAR Severe Adverse Reaction" -- "e) Is a congenital anomaly/birth defect"
    None were reported.


  • Hopeful they are age restricting the use.

  • hort: FDA is the most corrupt bunch of mafia people in USA!

    The Corruption of Science

    Bruce A. Chabner

    A view from a small fish in the pond...something rotten in the water

    "To counteract this corruption of science, it is vital that the scientific community speak with one voice to protest. The directors of government agencies such as the CDC and FDA must not succumb to the inappropriate pressure and political motivations of the administration and, if necessary, should resign rather than collaborate in misguided policies and messaging. Furthermore, our academies and national organizations must speak out to defend the sanctity of science and protect the health of our nation.

  • its not because hospitals don't have them, they do, but it looks like it's for the rich and famous and not the the general population

    Famous patients tout COVID-19 treatment, but the drug is slow to reach others…=en-US&gl=US&ceid=US%3Aen

    President Trump asserted the medication had cured him of COVID-19. Rudy Giuliani and former New Jersey governor Chris Christie raved about receiving it during their bouts of coronavirus.

    Yet only a fraction of the available doses of monoclonal antibodies have made it into the arms of less-famous patients, despite preliminary data suggesting the experimental drug might keep people out of the hospital.

  • Yes, now it looks like we can cut corners on vaccine distribution but even try an early treatment protocol and you are considered a dangerous

    U.S. could ramp up slow Covid vaccine rollout by giving two half volume doses of Moderna shot, Slaoui says…=en-US&gl=US&ceid=US%3Aen

    The head of the federal government's Covid-19 vaccine program said Sunday that health officials are exploring the idea of giving a major group of Americans half volume doses of one vaccine to accelerate the rollout.

    Moncef Slaoui, the head of Operation Warp Speed, said on CBS' "Face the Nation" that one way to speed up immunizations against Covid-19 was to give two half-volume doses of the Moderna vaccine to some individuals

  • S Africa COVID variant more infectious than UK strain: Hancock…=en-US&gl=US&ceid=US%3Aen

    British Health Secretary Matt Hancock has said the new COVID-19 variant identified in South Africa is a bigger risk than the highly infectious UK variant.

    “I’m incredibly worried about the South African variant, and that’s why we took the action that we did to restrict all flights from South Africa,” Hancock told BBC Radio on Monday.

  • Japan weighs state of emergency amid ‘severe’ COVID-19 surge…=en-US&gl=US&ceid=US%3Aen

    Japanese Prime Minister Yoshihide Suga said on Monday that he was considering declaring a state of emergency in the greater Tokyo area over a “very severe” third wave of COVID-19 infections, casting fresh doubt over whether Japan can push ahead with the Olympics and keep economic damage to a minimum.

    Japan saw a record 4,520 new cases on December 31, prompting the capital, Tokyo, and three neighbouring prefectures to seek an emergency declaration from the national government

  • Small study on ivermectin

    External Content
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • My friend had them, felt (50% better next day),

    but had to sign document saying she would not return to hospital?

  • How modelling Covid has changed the way we think about epidemics…-collaboration-experiment

    The events of last year have altered the dynamics of many diseases, beyond Covid-19, as seen in the disappearance of certain seasonal infections or the disruption of vaccination programmes. Had the pandemic not happened, I would have spent much of 2020 abroad, setting up studies of influenza, Zika and dengue. When these projects eventually resume, will we see smaller outbreaks than before, or belated large epidemics? The pandemic has created a tragic “natural experiment”, a once-in-a-century jolt to disease ecosystems that could produce unexpected insights into immunity, social behaviour, seasonal effects and evolution. We’ve learned a lot about Covid-19 in the past 12 months, but there’s much more that modelling will help us discover in the coming years.